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http:WHAT THIS PAPER ADDS
This is the largest single-center experience with the use of the new C3 Gore Excluder stent-graft. The C3 Gore
Excluder has a redesigned deployment mechanism that allows for multiple repositioning, both for level and
orientation, prior to ﬁnal deployment. This study shows that repositioning before ﬁnal stent-graft deployment is
feasible and safe in “real life” conditions. This new capability for multiple repositioning is frequently useful in
clinical practice and results in precise proximal deployment. Occasionally, however, adverse events can occur
when excessive repositioning is attempted.Objectives: To present results from the ﬁrst 100 patients treated with the new C3 Gore Excluder stent-graft in a
single institution.
Methods: All patients treated with the C3 Excluder stent-graft between August 2010 and July 2013 in our
institution were included. Patient demographics, treatment indication, need for intraoperative stent-graft
repositioning, immediate technical success, survival, endoleak and migration rate, and need for reintervention
during follow-up were analyzed.
Results: A total of 100 patients (86% male, mean age 71.1  9.3 years) were enrolled. Elective abdominal aortic
aneurysm (AAA) was the most common indication for treatment (n ¼ 90), followed by common iliac artery
aneurysm (n¼ 5), ruptured AAA (n¼ 2), type Ia endoleak (n¼ 1), and type IV endoleak (n¼ 1) after prior EVAR, and
penetrating aortic ulcer (n ¼ 1). Technical success was achieved in 98 patients. In two patients a small type I
endoleak persisted at completion angiography, but had disappeared at the ﬁrst control computed tomography
angiogram. Stent-graft repositioning after initial deploymentwas required in 49 patients, almost equally distributed
for level and contralateral gate reorientation. Exact positioning of the proximal trunk was achieved in 98 patients,
with the remaining two cases within 5 mm of the intended location. Adverse events related to repositioning
maneuvers were noticed in two cases. Mean follow-up durationwas 12.2 9.4months (range 0e36months). Eight
patients died, none from aneurysm related causes. Cumulative patient survival was 96.2  2.1% at 1 year, and
84 6.1% at 2 years, respectively. No migration, or type I or III endoleak was detected during follow-up. Estimated
freedom from reintervention was 96  2.4% at 1 year, and 91  5.2% at 2 years, respectively.
Conclusions: The new C3 Excluder stent-graft provides excellent short-term outcomes and offers important
advantages in terms of stent-graft repositioning to achieve high proximal deployment accuracy. Longer follow-up
is required to conﬁrm improved long-term outcome compared with the previous generation Excluder stent-graft.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Endovascular aortic aneurysm repair (EVAR) is now widely
regarded as the procedure of choice for patients with
suitable infrarenal abdominal aortic aneurysm (AAA).1,2
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//dx.doi.org/10.1016/j.ejvs.2013.12.015fundamental prerequisites for both early- and long-term
success of EVAR. Accurate proximal stent-graft deploy-
ment is therefore of importance, especially in marginally
suitable neck anatomies (short neck length, angulated
proximal neck).
Since the introduction of EVAR, two decades ago, stent-
graft manufacturers have been trying to enhance proximal
sealing aiming to increase anatomic eligibility, and to
improve early and long-term outcomes of EVAR.3,4 Gore
(W.L. Gore & Associates, Flagstaff, AZ, USA) introduced the
new C3 Excluder stent-graft to address the issue of proximal
deployment accuracy. The new C3 Excluder stent-graft of-
fers a redesigned deployment mechanism that allows for
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to ﬁnal deployment of the stent-graft.
The early use of the new C3 Excluder deployment system
in the ﬁrst 25 patients from GREAT (Global Registry for
Endovascular Aortic Treatment) has already been published,
and 1-year results of 400 patients included in GREAT are
awaited.5 In this report, we present our single-center
experience with the use of the C3 Excluder in 100 patients.
MATERIALS AND METHODS
Patient cohort
In our institution, patients with AAA that are anatomically
suitable for EVAR are always considered for endovascular
repair. Patients are informed about potential longevity issues
of EVAR and the need for life-long surveillance and are also
informed about open surgery as an alternative treatment
before reaching a ﬁnal decision. Open surgery is recom-
mended only for minimal risk young patients, or for patients
that are not willing to comply with a strict postoperative
surveillance protocol. All patients treated with a standard
infrarenal stent-graft are enrolled in a prospectively collected
database. Data of all patients that were treated with the C3
Excluder stent-graft between August 2010 and July 2013
were analyzed for this study. Patients treated both inside and
outside the instructions for use (IFU) were included. Patients
were considered to be outside IFU if:
1. the proximal neck length was less than 1.5 cm. This was
deﬁned as the distance between the lowest renal artery
and the origin of the aneurysmal dilation of the aorta;
and/or
2. the infrarenal neck angle was greater than 60 degrees.
Neck angle was deﬁned as the angle between the
aortic centerline above the lowest renal artery and the
centerline between the lowest renal artery and the
aortic bifurcation.
The indication for treatment was an AAA of at least 5 cm
in diameter (or a smaller AAA in conjunction with a com-
mon iliac artery aneurysm of at least 3 cm in diameter).
Patients with acute or ruptured AAA or with complications
after previous EVAR or open surgery were also included.
All included patients provided written informed consent
for their participation in the study. The study was approved
by our institution’s ethical committee. The ﬁrst 74 patients
were enrolled in GREAT (Global Registry for Endovascular
Aortic Treatment).
Stent-graft design
The C3 Gore Excluder (W.L. Gore & Associates, Flagstaff,
AZ, USA) is a third-generation stent-graft featuring an
original design with a ﬂexible, catheter-mounted intro-
duction, and active infrarenal attachment with barbs. The
deployment mechanism has been modiﬁed into a three-
step sequence, which enables repositioning of the stent-
graft up to three times prior to ﬁnal release from the
delivery catheter.5 In the ﬁrst step, the body andcontralateral limb are opened. A constraining loop around
the body of the stent-graft enables recapturing and
repositioning of the proximal trunk both for level and
orientation. In the second step the constraining wire is
removed after conﬁrmation of correct position. The ipsi-
lateral limb is deployed in a third separate step.
Procedure
All patients had a preoperative stent-graft plan featuring
the lengths and diameters of the chosen stent-grafts ac-
cording to their aortic and iliac dimensions. All procedures
were performed in a hybrid operating room with ﬁxed im-
aging system (Siemens Artis Zeego, Siemens, Erlangen,
Germany). General anesthesia and bilateral small femoral
cut down access were routinely used. The need for and
details of level and/or orientation repositioning were
documented for every procedure. Adjunctive procedures
(e.g., renal chimney) were also documented. Completion
angiography was routinely performed to document the ﬁnal
position of the stent-graft and potential endoleaks.
Technical success was deﬁned as successful deployment
of the stent-graft with no type I/III endoleak, unintentional
coverage of visceral aortic branches or hypogastric arteries
at the end of the procedure, and with successful removal of
the delivery system. Primary conversion was considered a
technical failure.
Follow-up
Patients were systematically followed according to our in-
stitution’s protocol. All treated patients are discharged with
an accompanying letter for their general practitioner stating
in detail the appropriate follow-up scheme [exact date and
method (CT, U/S) of follow-up)]. Over 90e95% of the patients
return to our center for clinical and imaging follow-up (inside
the hospital or via our out-patient clinic). For patients outside
our region (mostly fenestrated and branched and not that
many standard EVARs) we obtain the CT images and the
relevant follow-up letter and update our database. In case of
open issues, we do phone the general practitioner, the
referring vascular surgeon, or the patient/patient family.
Patients that had signs of endoleak at completion angi-
ography were followed with computed tomography angi-
ography (CTA) until the endoleak was treated or regressed
spontaneously. EVAR patients without endoleak were fol-
lowed with yearly ultrasound and abdominal X-ray. CTA was
reserved for patients in whom ultrasound showed endoleak
and/or aneurysm sac enlargement or when stent-graft
migration or dislodgement was seen on abdominal X-ray.
Detected endoleaks, stent-graft migration and reinter-
vention needed during follow-up were recorded. Time and
cause of death were also documented.
Statistical analysis
SPSS for Windows (version 17.0; SPSS Inc, Chicago, IL, USA)
was used for statistical analysis. Variables are presented as
mean  standard deviation (SD) in case of normal distri-
bution, and median plus range if data had a skewed
Table 2. Patients treated outside instructions for use.
Indication(s) outside IFU Patient N (%)
Neck length <1.5 cm 11 (11%)
Neck angulation >60 8 (8%)
Neck length <1.5 cm and
neck angulation >60
2 (2%)
344 A. Katsargyris et al.distribution. Statistical signiﬁcance was taken at p < .05.
Analyzed outcomes included technical success, number and
type of stent-graft repositioning, operative mortality and
morbidity, and late procedure-related events with regard to
endoleak, stent-graft migration, and reinterventions. Sur-
vival and reintervention during follow-up were subjected to
KaplaneMeier analysis.
RESULTS
Baseline data
Between August 2010 and July 2013, 100 patients (86%
male, mean age 71.1  9.3 years) were treated with the
new C3 Gore Excluder stent-graft. Patient demographics and
risk factors are summarized in Table 1.
Elective AAA was the most common indication for
treatment (n ¼ 90), followed by common iliac artery
aneurysm (n ¼ 5), ruptured AAA (n ¼ 2), type Ia endoleak
(n ¼ 1) and type IV endoleak (n ¼ 1) after prior EVAR, and
penetrating aortic ulcer (n ¼ 1).
In 95 out of 100 patients, C3 implantation was performed
as a primary procedure, while the remaining cases were
reintervention after prior endovascular (3/100) or open (2/
100) aortic procedures.
The mean maximum AAA diameter was 58.4  8.6 mm
(range 48e95 mm). Proximal aortic neck had a mean length
of 27.4  12 mm (range 10e60 mm) and a mean angulation
of 15.8  25 (range 0e90). A total of 17 of 100 patients
were treated outside the IFU for the C3 Excluder stent-graft
(Table 2).Procedure data
The procedure was performed under general anesthesia
and via femoral surgical cut-down in all cases. One patientTable 1. Patient demographics and risk factors.
Total number of patients n ¼ 100
Gender
Male 86%
Female 14%
Age (years)
Mean (SD) 71.1 (9.3)
Risk factors
Hypertension 75%
Hypercholesterolemia 63%
Tobacco use 50%
Coronary artery disease 46.0%
Peripheral arterial disease 28%
Chronic obstructive pulmonary disease 26%
Diabetes mellitus 14%
Renal insufﬁciency 8%
Renal dialysis 1.0%
Carotid disease 8%
ASA classiﬁcation
Number responding
I 3%
II 49%
III 47%
IV 1%with a short necked (10 mm) AAA and severely angulated
proximal neck underwent an additional planned right renal
artery chimney stenting via left axillary artery introduction
(Fig. 1). Median procedure duration was 84 minutes (range
48e335 minutes). Median estimated blood loss (EBL) was
160 mL (range 90e1600 mL). Median ﬂuoroscopy time was
12.4 minutes (range 6e150 minutes) and mean iodinated
contrast volume used 104.7  23 mL. The one patient with
a very long procedure time and ﬂuoroscopy time (335 and
150 minutes, respectively) had a type IV endoleak after
prior EVAR with a Powerlink stent-graft (Endologix, Irvine,
CA, USA). This aneurysm was planned for a complete
relining with a C3 Excluder stent-graft. Serious difﬁculties
were encountered during wire access, with the guidewire
being repeatedly trapped between the struts of the previ-
ously implanted Powerlink stent-graft.Intraoperative stent-graft repositioning and need for
proximal cuff extender
Sixty-nine proximal trunk repositionings were performed in
49 patients. One repositioning was required in 32 patients,
two in 14 patients, and three in three patients. The exact
planned position of the proximal trunk was achieved in 98
patients, with the remaining two within 5 mm of the
intended location. Adjunctive proximal cuff extender im-
plantation was not required in any of the patients. Read-
justment of the length of the ipsilateral limb after complete
opening of the proximal trunk in order to preserve the
hypogastric artery was performed in three patients. Table 3
summarizes the repositioning data. Repositioning of the
proximal trunk and the ipsilateral limb was always possible.
The back-up mechanism to open the stent-graft in case of
failure of the deployment system was never used. Adverse
events related to repositioning maneuvers were noticed in
two patients. In one patient, repetitive rotational reor-
ientation of the contralateral gate caused a twist in the
ipsilateral limb. This was diagnosed at the 1-month post-
operative CTA. Although the patient had good femoral
pulses, it was decided to treat him prophylactically. Addi-
tional stenting (self-expanding stent 10  40 mm, Absolute
Pro Vascular, Abbott Vascular, Hessen, Germany) was per-
formed after complete wound healing 2 months post-
operatively (Fig. 2). In a second patient, excessive upward
readjustment of the ipsilateral limb to preserve the hypo-
gastric artery resulted in upward migration of the proximal
trunk, partially covering the left renal artery. This was
diagnosed at completion angiography and immediately
treated with a chimney stent to secure the left renal artery6
(Fig. 3).
Figure 1. (A) Preoperative computed tomography angiography demonstrating a juxtarenal abdominal aortic aneurysm with short and
extreme angulated neck. (B) Intraoperative ﬂuoroscopy showing treatment with a C3 Excluder stent-graft and a right renal chimney stent.
(C) Completion angiogram demonstrating successful exclusion of the aneurysm and maintained patency of the right renal artery.
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Technical success was achieved in 98 patients. In two pa-
tients a small type I endoleak persisted at completion
angiography, but had disappeared at the ﬁrst control CTA.
Intraoperative and 30-day mortality was zero. Postoperative
complications occurred in ﬁve patients. One patient devel-
oped a capsular hematoma of the right kidney, caused by
wire manipulation (accidental catheterization of the right
renal artery). This hematoma was treated conservatively
with success. One patient suffered an acute myocardial
infarction requiring coronary angiography. One patient
developed temporary acute renal failure due to a contrast
reaction. Finally, two patients developed a groin hematoma
treated conservatively in both cases.
Admission to the ICU was required in eight patients, in two
of them for longer than 24 hours. Reasons for ICU admission
were severe chronic obstructive pulmonary disease in two
patients, capsular hematoma of the kidney, renal function
surveillance due to high preoperative creatinine values,
prolonged procedure duration preventing immediate post-
operative extubation, preoperative cardiovascular collapse,
postoperative hypotension with ST depression in the elec-
trocardiogram, and difﬁcult intubation due to rheumatoid
arthritis causing edema of the vocal cords.Table 3. Summary of proximal trunk repositioning data.
Number of patients required trunk repositioning 49 (49%)
Episodes of trunk repositioning 69
Episodes of ipsilateral limb length readjustment 3
Reasons for proximal trunk repositioning
Positioning closer to renal arteries 23/69
(33%)
Positioning lower to uncover
the renal arteries
12/69
(17.4%)
Contralateral gate positioning 34/69
(49.3%)
Number of repositions per case
Mean (SD) 0.7 (0.8)
Range (0.0e3.0)
Number of repositions per case
0 51 (51%)
1 32 (32%)
2 14 (14%)
3 3 (3%)Mean hospital stay including preoperative admission
day(s) was 5.9  1.7 days. All patients left hospital in good
condition. No secondary intervention was required within
30 days of the procedure.Follow-up
Mean follow-up duration was 12.2  9.4 months (range 0e
36 months). Two patients were lost from follow-up, both
after 1 year. One was referred to us from another country,
and one suffered a stroke and refused further clinical ex-
amination and imaging. Eight patients died during follow-
up, none from aneurysm-related causes. Two patients
died of acute myocardial infarction, two of pulmonary
infection, one of sepsis, one of amyotrophic lateral sclerosis,
one due to traumatic brain injury, and one due to compli-
cations following hip fracture. Cumulative patient survival
estimated by KaplaneMeier was 96.2  2.1% at 1 year, and
84  6.1% at 2 years (Fig. 4A). During follow-up, no
migration or type I or III endoleak was detected and no
patient required conversion to open repair. A total of eight
type II endoleaks were observed during follow-up. Two of
them were treated with lumbar artery embolization, while
the remaining six were followed, as there was no AAA sac
enlargement. Reintervention during follow-up was required
in four patients, including the two previously mentioned
lumbar artery embolizations and the preventive stenting of
the ipsilateral limb twist. The last reintervention was the
chimney stent for the left renal artery: this one occluded at
5 months and was immediately restented with success.
Estimated freedom from reintervention was 96  2.4% at 1
year, and 91  5.2% at 2 years, respectively (Fig. 4B).
DISCUSSION
Accurate proximal stent-graft deployment is essential in both
standard and challenging proximal necks, in order to achieve
initial, but also long-term success of EVAR. To address this
issue, Gore recently revised the Excluder stent-graft, intro-
ducing the new C3 Excluder, featuring a deployment mech-
anism that allows multiple reconstraining and repositioning
of the stent-graft before ﬁnal deployment. The new C3
deployment mechanism enables multiple readjustments of
the Excluder stent-graft for (a) proximal level, (b) orientation,
Figure 2. (A) Twisting causing stenosis of the ipsilateral limb (arrow) after repeated reorientation maneuvers to facilitate contralateral gate
cannulation. (B) Successful treatment with a bare stent.
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reposition the stent-graft for proximal level enables accurate
deployment with regard to the renal arteries. This is an
advantage both for inexperienced clinicians (second and
third chance for deployment at the right level), and for
experienced clinicians (in case of challenging neck anatomy).
The option for rotational readjustment can be useful in cases
of difﬁcult contralateral gate cannulation, where the prox-
imal trunk can be reconstrained and the gate reoriented to a
more convenient location for catheterization. Finally, the
separate deployment of the ipsilateral limb allows for limb
length adaptation. The ipsilateral limb can be readjusted for
level by meticulously pushing the delivery catheter upwards
during slow controlled deployment. This can correct inad-
vertent overstenting of the hypogastric artery.6
The present experience on 100 patients shows that the
new deployment system enables easy and safe reposition-
ing of the proximal trunk. Repositioning was always possible
when attempted. The exact inﬂuence of repositioning on
outcomes is difﬁcult to assess. Proximal deployment accu-
racy although subjectively assessed by the operator was
high (98% deployment at the exact desired position). A
more objective indication of proximal deployment
improvement is the zero use of proximal cuffs (but biased in
a positive way, as indication for standard EVAR are strict,
and fenestrated EVAR is employed with low threshold).
Compared with older EVAR series, where proximal cuffs
were used in up to 19% of cases, this represents a clear
improvement in proximal deployment accuracy.7,8
Although no failures to reposition the stent-graft were
encountered in this patient cohort, risks associated with
excessive repositioning maneuvers can occasionally arise.
Reconstraining the stent-graft and upward level repositioning
may be difﬁcult in narrow and/or angulated neck anatomy,
although no adverse events were noticed in this cohort.
Excessive rotational reorientation may cause twist of the
ipsilateral limb. Moreover, proximal position can be lostduring rotational reorientation requiring new repositioning
for level. Finally, excessive upward readjustment of the ipsi-
lateral limb, aiming to avoid hypogastric artery overstenting,
may result in upward migration of the proximal trunk.6
Based on current clinical experience, relevant advice was
developed to eliminate these repositioning associated risks.
In narrow and/or angulated neck anatomy, where upwards
repositioning of the stent-graft can be difﬁcult, the stent-graft
should be deployed at the level of the renal arteries or higher,
with lower repositioning if needed. Positioning the stent-
graft deliberately above the renal arteries is also useful in
relining procedures after previous EVARwith limited working
length due to the high neo-bifurcation. Once catheterization
of the contralateral limb has been achieved the stent-graft
can be pulled down below the renal arteries. Ipsilateral
limb twist due to extensive rotational reorientation can be
identiﬁed and corrected during slow deployment under
ﬂuoroscopy. Finally, attention should be paid to conﬁrm that
the proximal edge of the stent-graft remains in position
during pushing-up of the ipsilateral limb to adjust its length. It
is however fair to say that in the one case this misfortune
happened, the limb was pushed upwards far too high.
With the new C3 Excluder stent-graft a new (optional)
deployment sequence was developed.5 Brieﬂy, after prox-
imal trunk deployment, contralateral gate cannulation is
attempted, if required, with reorientation of the stent-graft.
Upon successful catheterization, the proximal position is
controlled by angiography and the stent-graft repositioned
for level if needed. Thereafter the proximal trunk is
completely opened and the ipsilateral limb deployed. This
approach was initially used, aiming for quicker catheteri-
zation of the contralateral gate and reduced ﬂuoroscopy
duration. With more experience, however, we have become
more conservative again and allow for some time for
catheterization, in order to avoid repetitive reorientation
and possible torsion of the ipsilateral limb. An overall
repositioning rate of 49% is therefore a bit excessive.
Figure 3. (A) Retrograde i.a. angiography demonstrating the long undeployed ipsilateral limb over the iliac bifurcation. (B) Readjustment of
the ipsilateral limb in order to preserve hypogastric artery patency by pushing the delivery catheter up during slow deployment of the limb.
(C,D) This resulted to upward migration of the proximal trunk and left renal artery coverage that was successfully treated with a renal stent.
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treated outside C3 Excluder’s IFU. Delivery and deployment
of the stent-graft did not seem to be inﬂuenced by these
wider inclusion criteria. The stent-graft was successfully
deployed at the exact planned position in 16 out of 17
(94%) cases outside the IFU. No signiﬁcant difference in theneed for repositioning was noticed between cases outside
IFU and those within IFU (49.4% vs. 50.6%). Despite these
early encouraging results, longer follow-up is required to
prove durability of treatment outside IFU.
The perioperative and short-term outcomes of this study,
including zero 30-day mortality and reintervention, and low
Figure 4. (A) KaplaneMeier estimate of the cumulative overall patient survival for all-cause mortality during follow-up. (B) KaplaneMeier
estimate of freedom from reinterventions during follow-up.
348 A. Katsargyris et al.reintervention during 1-year follow-up, compare well with
the landmark EVAR-1 and DREAM trials.9,10 This observation
might imply that outcomes of EVAR as reported in older
studies may not accurately reﬂect the current status of the
technique, if applied with care and in the right patients.
Short-term outcomes of EVAR have certainly improved over
the years due to better device technology and accumulated
clinical experience.
CONCLUSIONS
The use of the new C3 Excluder stent-graft in 100 patients in
our institution showed excellent short-term outcomes. The
new opportunity for multiple repositioning before deﬁnitive
stent-graft opening is frequently useful in clinical practice
and results in precise proximal deployment. Longer follow-
up is needed to conﬁrm improved durability and reduced
need for late reintervention.
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